🇺🇸 Amoxicillin Capsules in United States
110 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 110
Most-reported reactions
- Drug Hypersensitivity — 18 reports (16.36%)
- Rash — 15 reports (13.64%)
- Diarrhoea — 14 reports (12.73%)
- Nausea — 12 reports (10.91%)
- Pruritus — 11 reports (10%)
- Headache — 10 reports (9.09%)
- Fatigue — 8 reports (7.27%)
- Malaise — 8 reports (7.27%)
- Dizziness — 7 reports (6.36%)
- Drug Ineffective — 7 reports (6.36%)
Other Infectious Disease approved in United States
Frequently asked questions
Is Amoxicillin Capsules approved in United States?
Amoxicillin Capsules does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Amoxicillin Capsules in United States?
The Third Xiangya Hospital of Central South University is the originator. The local marketing authorisation holder may differ — check the official source linked above.